Company news
Nuvo Pharmaceuticals Inc news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Miravo Healthcare(TM) to Present at Q1 Virtual Investor Summit
February 28, 2022
Miravo Healthcare(TM) to Present at the SNN Network Canada Virtual Event on Wednesday, December 8, 2021
November 25, 2021
Miravo Healthcare(TM) Announces Receipt of Health Canada Notice of Compliance for the Pediatric Use of Blexten®
August 12, 2021
Miravo Healthcare(TM) Announces Second Quarter 2021 Results
August 9, 2021
Miravo HealthcareTM Ireland Enters into Suvexx® License and Supply Agreement with SK Chemicals Co., Ltd. for South Korea
July 29, 2021
Miravo Healthcare(TM) Announces Second Quarter 2021 Results Release Date and Conference Call Details
July 26, 2021
Miravo Healthcare(TM) to Present at Access to Giving Virtual Investor Conference
July 8, 2021
Miravo Healthcare(TM) to Present at Summer Solstice - Best Ideas from the Buy Side
May 27, 2021
Miravo Healthcare(TM) Announces Appointment of Mary Ritchie to its Board of Directors
May 19, 2021
Miravo Healthcare(TM) Announces Director Election Results of its Annual Meeting of Shareholders
May 17, 2021
Miravo Healthcare(TM) Announces First Quarter 2021 Results
May 17, 2021
Miravo Healthcare(TM) to Present at Q2 Virtual Investor Summit
May 11, 2021
Miravo Healthcare(TM) Announces First Quarter 2021 Results Release Date and Virtual Annual Meeting of Shareholders
May 3, 2021
Miravo Healthcare(TM) Files Final Base Shelf Prospectus
April 21, 2021
Miravo Healthcare(TM) to Present at the Planet MicroCap Showcase: VIRTUAL on Thursday, April 22, 2021 at 10: 00 a.m. EST
April 12, 2021
Miravo Healthcare(TM) to Present at Upcoming Investor Conferences
April 9, 2021
Miravo Healthcare(TM) Acknowledged In The Globe and Mail's Second-Annual Women Lead Here Benchmark of Executive Gender Diversity
March 26, 2021
Miravo Healthcare(TM) to Present at Q1 Virtual Investor Summit
March 11, 2021
Miravo Healthcare(TM) Files Preliminary Base Shelf Prospectus
March 8, 2021
Miravo Healthcare(TM) Announces 2020 and Fourth Quarter Results
March 8, 2021
Miravo Healthcare(TM) Ireland Enters into Resultz® License and Supply Agreement with The Mentholatum Company for the United States
March 1, 2021
Miravo Healthcare(TM) Announces Fourth Quarter 2020 Results Release Date and Conference Call Details
February 22, 2021
Miravo Healthcare(TM) to Host Investor Webcast on January 28, 2021 at 2: 00 p.m. EST
January 14, 2021
Miravo Healthcare(TM) Announces the Canadian Commercial Launch of NeoVisc®+ and NeoVisc® ONE for the Treatment of Pain and Improvement of Joint Functionality of the Knee
January 13, 2021
Miravo Healthcare(TM) Ireland Enters into Suvexx® License and Supply Agreement with Orion Corporation for Select EU Markets
December 21, 2020
Nuvo Pharmaceuticals® Announces Corporate Rebranding as Miravo Healthcare(TM)
December 18, 2020
Nuvo Pharmaceuticals® Announces Third Quarter 2020 Results
November 16, 2020
Nuvo Pharmaceuticals(TM) Announces Third Quarter 2020 Results Release Date and Conference Call Details
November 2, 2020
Nuvo Pharmaceuticals® to Webcast Live at VirtualInvestorConferences.com October 8th
October 5, 2020
Nuvo Pharmaceuticals® to Webcast Live at Life Sciences Investor Forum September 17th
September 14, 2020
Nuvo Pharmaceuticals® Announces The Canadian Commercial Launch of Suvexx(TM) - For The Acute Treatment of Migraine
September 9, 2020
Nuvo Pharmaceuticals® Announces Second Quarter 2020 Results
August 10, 2020
Nuvo Pharmaceuticals(TM) Announces Second Quarter 2020 Results Release Date and Conference Call Details
July 27, 2020
Nuvo Pharmaceuticals® Announces Director Election Results of its Annual & Special Meeting of Shareholders
May 12, 2020
Nuvo Pharmaceuticals® Announces First Quarter 2020 Results
May 11, 2020
Nuvo Pharmaceuticals® Announces First Quarter 2020 Results Release Date and Virtual Annual & Special Meeting of Shareholders
April 27, 2020
Nuvo Pharmaceuticals® Announces Approval of Takeda's Cabpirin Tablets in Japan, Triggering a US$2.0 Million Milestone Payment due in Q2 2020
March 31, 2020
Nuvo Pharmaceuticals® to Webcast Live at Life Sciences Investor Forum March 26th
March 23, 2020
Nuvo Pharmaceuticals® Announces "at risk" Launch of Generic Version of Vimovo in the United States
March 4, 2020
Nuvo Pharmaceuticals® Announces Health Canada Approves Suvexx(TM) For The Acute Treatment of Migraine
February 27, 2020
Nuvo Pharmaceuticals® Announces 2019 and Fourth Quarter Results
February 25, 2020
Nuvo Pharmaceuticals(TM) Responds to Market Activity
February 11, 2020
Nuvo Pharmaceuticals(TM) Announces Fourth Quarter 2019 Results Release Date and Conference Call Details
February 11, 2020
Nuvo Pharmaceuticals(TM) Announces Repayment of Bridge Loan and Entitlement to Receive 2019 Vimovo U.S. Annual Minimum Royalty
January 7, 2020
Nuvo Pharmaceuticals(TM) Announces United States District Court Denies Dr. Reddy's Laboratories Motion for Summary Judgment of Nuvo's '996 and '920 VIMOVO Patents
November 11, 2019
Nuvo Pharmaceuticals(TM) Announces 2019 Third Quarter Results
October 31, 2019
Nuvo Pharmaceuticals(TM) Announces Third Quarter 2019 Results Release Date and Conference Call Details
October 17, 2019
Nuvo Pharmaceuticals(TM) to Present at H.C. Wainwright Global Investment Conference
September 4, 2019
Nuvo Pharmaceuticals(TM) Announces 2019 Second Quarter Results
August 14, 2019
Nuvo Pharmaceuticals(TM) Announces Second Quarter 2019 Results Release Date and Conference Call Details
July 31, 2019